Effect of First Myocardial Ischemic Event on Renal Function

American Journal of Cardiology

Volumn 100, Issue 1, 2007, Pages 7-12

  Eijkelkamp, Wouter B A ^a   de Graeff, Pieter A ^a   van Veldhuisen, Dirk J ^a   van Dokkum, Richard P E ^a   Gansevoort, Ronald T ^a   de Jong, Paul E ^a   de Zeeuw, Dick ^a   Hillege, Hans L ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; CREATININE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RENAL INSUFFICIENCY; RISK FACTORS;

EID: 34250751752     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.02.047     Document Type: Article

References (19)

1. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
2. Mann J.F., Gerstein H.C., Pogue J., Bosch J., and Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134 (2001) 629-636
3. Hillege H.L., Nitsch D., Pfeffer M.A., Swedberg K., McMurray J.J., Yusuf S., Granger C.B., Michelson E.L., Ostergren J., Cornel J.H., et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113 (2006) 671-678
4. Sarnak M.J., Levey A.S., Schoolwerth A.C., Coresh J., Culleton B., Hamm L.L., McCullough P.A., Kasiske B.L., Kelepouris E., Klag M.J., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 108 (2003) 2154-2169
5. van Dokkum R.P., Eijkelkamp W.B., Kluppel A.C., Henning R.H., van Goor H., Citgez M., Windt W.A., van Veldhuisen D.J., de Graeff P.A., and de Zeeuw D. Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interaction. J Am Soc Nephrol 15 (2004) 3103-3110
6. Hillege H.L., van Gilst W.H., van Veldhuisen D.J., Navis G., Grobbee D.E., de Graeff P.A., and de Zeeuw D. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J 24 (2003) 412-420
7. Pinto-Sietsma S.J., Janssen W.M., Hillege H.L., Navis G., de Zeeuw D., and de Jong P.E. Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol 11 (2000) 1882-1888
8. Hillege H.L., Janssen W.M., Bak A.A., Diercks G.F., Grobbee D.E., Crijns H.J., van Gilst W.H., de Zeeuw D., and de Jong P.E. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 249 (2001) 519-526
9. Verhave J.C., Gansevoort R.T., Hillege H.L., Bakker S.J., de Zeeuw D., and de Jong P.E. An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. Kidney Int 92 suppl (2004) S18-S21
10. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 suppl (2002) S1-S266
11. Hillege H.L., Fidler V., Diercks G.F., van Gilst W.H., de Zeeuw D., van Veldhuisen D.J., Gans R.O., Janssen W.M., Grobbee D.E., and de Jong P.E. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106 (2002) 1777-1782
12. Yuyun M.F., Adler A.I., and Wareham N.J. What is the evidence that microalbuminuria is a predictor of cardiovascular disease events?. Curr Opin Nephrol Hypertens 14 (2005) 271-276
13. Karalliedde J., and Viberti G. Microalbuminuria and cardiovascular risk. Am J Hypertens 17 (2004) 986-993
14. Gerstein H.C., Mann J.F., Yi Q., Zinman B., Dinneen S.F., Hoogwerf B., Halle J.P., Young J., Rashkow A., Joyce C., Nawaz S., and Yusuf S. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286 (2001) 421-426
15. Windt W.A., Eijkelkamp W.B., Henning R.H., Kluppel A.C., de Graeff P.A., Hillege H.L., Schafer S., de Zeeuw D., and van Dokkum R.P. Renal damage after myocardial infarction is prevented by renin-angiotensin-aldosterone-system intervention. J Am Soc Nephrol 17 (2006) 3059-3066
16. Anavekar N.S., McMurray J.J., Velazquez E.J., Solomon S.D., Kober L., Rouleau J.L., White H.D., Nordlander R., Maggioni A., Dickstein K., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
17. Bleiler R., and Schedl H.P. Creatinine excretion: variability and relationships to diet and body size. J Lab Clin Med 59 (1962) 945-955
18. Perrone R.D., Madias N.E., and Levey A.S. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 38 (1992) 1933-1953
19. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41